Skip to content
The Great Grantsby G

Cancer Research Institute

Clinical Innovator

$1M| Deadline: 1 December 2026 (in 37 days)

Protocol concept deadline

Last seen in a scan/import: .

Catalog updated: .

These timestamps are not source verification. Confirm the current deadline and your eligibility on the funder’s call page before applying.

Closes 1 Dec 2026. Add it to your calendar, then see what else you're eligible for. Check my fit for this call →

CRI Clinical Innovator provides up to $1 million per investigator-led immunotherapy trial. It supports phase I/II or II studies, mechanistic work and biomarkers.

Details

Funder Cancer Research Institute
Budget $1M
Deadline 1 December 2026
Consortium No - individual Principal Investigator applies
Application 2-stage: protocol concept → full proposal
TRL 6-9
Frequency Annual

Eligibility & scope

Supports pioneering immunotherapy clinical trials designed and led by academic researchers.

Who Should Apply

  • •The applicant must lead the proposed study at a nonprofit medical school or research centre; international applicants may apply.

Key Dates

  • •Protocol concept: 1 December 2026. Invited full proposal: 1 April 2027. Cutoff: 23:59 Eastern Time.

Tips for Applicants

  • ✓Indirect costs up to 10% are additional. A co-funded chordoma opportunity is available.

Frequently Asked Questions

Can I submit directly to the full stage?

No. CRI first reviews protocol concepts and invites selected applicants.

criclinical-trialsimmunotherapy
View full call →
Share ✉ Email X LinkedIn WhatsApp

Summary generated by AI based on published grant information. Always verify details on the funder's website.

Similar grants

Browse all open grants →

Browse Related

Closing in December 2026

Could Clinical Innovator be right for you?

See your personalised match score for this grant and others in 30 seconds. No signup needed to preview.

See my matches free →